|

Solriamfetol 150 MG Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Axsome Therapeutics, Inc.1

Indications

  • Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms1
  • Depression1

Chino, California1 trial

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Clinical Research Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.